Singapore, July 5, 2023: L’Oréal presents at the World Congress of Dermatology (WCD) in Singapore, its vision for the future of dermatology by unveiling its new research and innovations in the field of skin health. For this edition, the best dermatologists, scientists and researchers in the world meet at the World Congress of Dermatology (WCD) to discuss the latest advances.
Reference studies
L’Oréal’s Dermatological Beauty Division (LDB) today unveils the results of two international skin health studies carried out respectively by La Roche-Posay (LRP) and Vichy:
In the LRP study, the largest of its kind to date involving 48,000 people in 34 countries, half of the participants (50%) reported pigmentation disorders such as vitiligo, post-hyperpigmentation inflammation or melasma. Nearly a third (28%) claim to have lost quality of life due to these disorders, and 44% indicate that they hide the affected part of their body.
According to the conclusions of a survey carried out by Vichy among 20,000 women in 20 countries, 72% of them feel that hormonal variations have a negative impact on their well-being, and the majority (three out of four women) declare that skin problems occur or worsen during menstruation.
L’Oréal draws on decades of innovations validated by dermatologists and developed by more than 4,000 scientists, to offer new products and services that help to better diagnose, prevent and treat a large number of diseases of the skin. skin. As part of the World Congress of Dermatology, L’Oréal will present its latest innovations in the fields of skin defence, photoprotection, pigmentation and skin aging, all against a backdrop of sustainable development and inclusion.
New ingredients and
Green Sciences
Mexoryl 400
is the patented flagship ingredient of
UVMune 400 by La Roche-Posay
the very first L’Oréal technology for protecting the skin against ultra-long UVA rays and preventing skin damage linked to photoaging, photopollution and the modification of genes that can lead to skin cancer.
Pro-Xylane by L’Oreal Paris
is the first active ingredient from
Green Science
, made from sugars naturally present in beech bark. Invented more than 20 years ago, the Pro-Xylane molecule has since been patented and has become one of L’Oréal’s references in terms of solutions against skin aging.
THE
madecassoside
contained in the
Cicaplast B5 Balm by La Roche-Posay
is extracted from the leaves of
Centella Asiatica
, combined with water and ethanol derived from sugar cane. This plant extract known for its antioxidant and anti-inflammatory properties helps strengthen the skin barrier.
“We are delighted to return to the World Congress of Dermatology armed with new skin health data that complements the important work of the dermatology community,”
said
Barbara Lavernos, Deputy General Manager in charge of Research, Innovation and Technology of the L’Oréal Group.
“Our extensive research, innovation and growing investments in technology allow us to help solve the most pressing skin and hair problems, from hyperpigmentation to sun protection, acne, dryness and more to help more people have healthier skin and a better quality of life.
“In partnership with dermatologists around the world, we advance skin health for all, in their infinite diversity”,
added
Myriam Cohen-Welgryn, General Director Dermatological Beauty of the L’Oréal Group.
“By participating in the enrichment of scientific knowledge, by creating new sustainable products and enhanced services, and by supporting people waiting for solutions, we are helping to promote access to healthy skin for an ever-increasing number of people. important to people all over the world. »
About L.
‘
Oreal
For more than 110 years, L’Oréal, the world leader in beauty, has been dedicated to a single vocation: to meet the beauty aspirations of consumers around the world. Our purpose, to create beauty that moves the world forward, defines our vision of beauty, inclusive, ethical, generous and responsible. With a portfolio of 36 international brands and ambitious commitments to sustainable development, set out in our L’Oréal for the Future program, we offer our consumers around the world the best in beauty in terms of quality, efficiency , security, sincerity and responsibility, while celebrating beauty in its infinite diversity.
With 87,400 committed employees, a balanced geographical presence and in all distribution channels (e-commerce, mass market, department stores, pharmacies and drugstores, hair salons, travel retail and branded boutiques), the Group has achieved in 2022 a turnover of 38.26 billion euros. L’Oréal relies on 20 research centers in 11 countries, a team dedicated to Research & Innovation of more than 4,000 researchers and 5,500 Tech and digital professionals, to invent the future of beauty and become the champion of Beauty Tech.
More information on https://www.loreal.com/fr/mediaroom
Contact L’Oreal
Individual Shareholders and Market Authorities
Pascale GUERIN – Tel: 01 49 64 18 89 –
[email protected]
Financial Analysts and Institutional Investors
Françoise LAUVIN – Tel: 01 47 56 86 82 –
[email protected]
Media
Noelle CAMILLERI – Tel: 06 79 92 99 39 –
[email protected]
Brune DIRICQ – Tel: 06 63 85 29 87 –
[email protected]
Christine BURKE – Tel: 06 75 54 38 15 –
Attachment
PR_WORLD CONGRESS OF DERMATOLOGY – THE LORÉAL GROUP UNVEILS NEW STUDIES ON PIGMENTATION AND THE IMPACT OF HORMONAL VARIATIONS ON WOMEN’S SKIN AND SCALP